echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Formula particle pilot enterprise sits another member, and the team has been expanded to more than 60

    Formula particle pilot enterprise sits another member, and the team has been expanded to more than 60

    • Last Update: 2020-07-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "Pharmaceutical Network Industry Dynamics" Liu Pharma shares announced on the evening of July 1, the company's holding subsidiary Wantong Pharmaceutical recently received the Guangxi Zhuang Autonomous Region Department of Industry and Information Technology issued "on the announcement of the 2020 China medicine formula particle research pilot list (first batch) notice", to determine wantong Pharmaceutical stake in Guangxi Zhuang Autonomous Region, Chinese medicine formula particle research pilot enterprisesthis means that the domestic formula particle pilot enterprises to add another memberChinese medicine formula particles are based on traditional Chinese medicine tablets as raw materials, from a single taste of Chinese medicine tablets after water, concentration, drying, granulation, in the clinical formula of Chinese medicine, for patients to take the usehas the advantages of simple to take, easy to carry, controlled quality and clear efficacyApril 2001, the Interim Regulations on the Administration of Chinese Medicine Formula Particles were promulgated, incorporating Chinese medicine formula particles into the scope of Chinese medicine drink tablets management, and implementing the approval number management6 enterprises (Jiangyin Tianjiang Pharmaceuticals, China Resources 39 Modern Chinese Medicine, Guangdong Side Pharmaceutical Co., Ltd., Sichuan New Green Pharmaceuticals, Beijing Kangrentang Pharmaceuticals, Nanning Peili Pharmaceuticals) obtained the national pilot qualification, occupying most of the market share2015, after the publication of the Measures for the Management of Chinese Medicine Formula Particles (Draft for Comments), Hebei, Zhejiang, Heilongjiang, Jilin, Anhui, Shaanxi, Henan, Shandong, Jiangxi, Guangdong and other provinces have issued documents to approve the pilot enterprises of Chinese medicine formula particles in the province in the name of scientific research, pilot research, clinical pilot, technical reform and other special, and carry out the pilot research and production of Chinese medicine formula particles and medical institutionsthe current pilot qualified enterprises in addition to Wantong Pharmaceuticals and six national pilot enterprises, on February 26 this year, Guizhou approved a (Guizhou Yiyi Pharmaceutical Co., Ltd.), in March 2019, Guizhou Provincial Drug Administration has confirmed that the State Pharmaceutical Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Guiyang Xintian Pharmaceutical Co., Ltd2 pilot enterprises; A total of 8 (including Qingzhou Yanwang Pharmaceutical Co., Ltd., Shandong Hongjitang Pharmaceutical Group Co., Ltd., Shandong One Pharmaceutical Co., Ltd., Inner Mongolia Pukang Pharmaceutical Co., Ltd., Kamon Co., Ltd., Inner Mongolia Mongolian Pharmaceutical Co., Ltd., Inner Mongolia Beijing New Pharmaceutical Co., Ltd., Baotou Chinese Medicine Co., Ltd.); According to incomplete statistics in the industry, the current national access to various types of Chinese medicine formula particles pilot qualification of enterprises have more than 60it is understood that due to the unstable quality of formula particles, the legal standards have yet to be perfectedNovember 8, 2019, the Comprehensive Division of the State Drug Administration announced the "Technical Requirements for Quality Control and Standard-Setting of Chinese Medicine Formula Particles" issued by the State Administration of Chinese Medicine, which has a more detailed requirement for Chinese medicine formula particlesOn the same day of, the National Pharmacopoeia Commission issued the "Publicity on the Pilot Uniform Standards for The Pilot Of Chinese Medicine Formula Varieties", and published the unified standards for the pilot of 160 varietiesthe release of the standard, releasing the industry from the pilot to the official production, the market gradually liberalized the positive signalin recent years, the formula particle market is growing, is expected to reach 25.5 billion yuan by 2020in the face of The Chinese medicine formula particles considerable development space, many Chinese medicine pilot enterprises actively layout according to industry statistics, the domestic Chinese medicine formula particle pilot qualification of enterprises, there are more than 30 listed pharmaceutical companies have been in the layout or will soon layout of Chinese medicine formula particles, and sales of larger pharmaceutical enterprises such as Chinese traditional medicine, Red Day pharmaceutical industry and other performance growth in recent years is obvious
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.